Year: 2023
Type: article
Abstract: OBJECTIVE: Magnetic resonance imaging (MRI) of the brain or spine examines the findings as well as the time interval between the onset of symptoms and other adverse effects in coronavirus disease that first appeared in 2019 (COVID-19) patients. The goal of this study is to look at studies that use neuroimaging to look at neurological and neuroradiological symptoms in COVID-19 patients. METHODS: We try to put together all of the research on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurological symptoms and cognitive-behavioral changes and give a full picture. RESULTS: We have categorized neuroimaging findings into subtitles such as: headache and dizziness; cerebrovascular complications after stroke; Intracerebral Hemorrhage (ICH); Cerebral Microbleeds (CMBs); encephalopathy; meningitis; encephalitis and myelitis; altered mental status (AMS) and delirium; seizure; neuropsychiatric symptoms; Guillain-Barre Syndrome (GBS) and its variants; smell and taste disorders; peripheral neuropathy; Mild Cognitive Impairment (MCI); and myopathy and myositis. CONCLUSION: In this review study, we talked about some MRI findings that show how COVID-19 affects the nervous system based on what we found.
Source: PubMed Central
Institutions: Tehran University of Medical Sciences, Kermanshah University of Medical Sciences, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Babol University of Medical Sciences, Shahrekord University, Shahrekord University of Medical Sciences, Iran University of Medical Sciences, Isfahan University of Medical Sciences, Kurdistan University of Medical Sciences, Tabriz University of Medical Sciences, Semnan University of Medical Sciences, Ahvaz Jundishapur University of Medical Sciences
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4377221155